Slomka Piotr, Berman Daniel S, Alexanderson Erick, Germano Guido
Departments of Imaging and Medicine, and Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA ; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
Departments of Imaging and Medicine, and Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
Clin Transl Imaging. 2014 Aug 1;2(4):343-358. doi: 10.1007/s40336-014-0070-2.
Positron Emission Tomography (PET) has several clinical and research applications in cardiovascular imaging. Myocardial perfusion imaging with PET allows accurate global and regional measurements of myocardial perfusion, myocardial blood flow and function at stress and rest in one exam. Simultaneous assessment of function and perfusion by PET with quantitative software is currently the routine practice. Combination of ejection fraction reserve with perfusion information may improve the identification of severe disease. The myocardial viability can be estimated by quantitative comparison of fluorodeoxyglucose (FDG) and rest perfusion imaging. The myocardial blood flow and coronary flow reserve measurements are becoming routinely included in the clinical assessment due to enhanced dynamic imaging capabilities of the latest PET/CT scanners. Absolute flow measurements allow evaluation of the coronary microvascular dysfunction and provide additional prognostic and diagnostic information for coronary disease. Standard quantitative approaches to compute myocardial blood flow from kinetic PET data in automated and rapid fashion have been developed for N-ammonia, O-water and Rb radiotracers. The agreement between software methods available for such analysis is excellent. Relative quantification of Rb PET myocardial perfusion, based on comparisons to normal databases, demonstrates high performance for the detection of obstructive coronary disease. New tracers, such as F-flurpiridaz may allow further improvements in the disease detection. Computerized analysis of perfusion at stress and rest reduces the variability of the assessment as compared to visual analysis. PET quantification can be enhanced by precise coregistration with CT angiography. In emerging clinical applications, the potential to identify vulnerable plaques by quantification of atherosclerotic plaque uptake of FDG and F-sodium fluoride tracers in carotids, aorta and coronary arteries has been demonstrated.
正电子发射断层扫描(PET)在心血管成像中有多种临床和研究应用。PET心肌灌注成像能够在一次检查中准确地对心肌灌注、心肌血流以及静息和负荷状态下的心肌功能进行整体和局部测量。目前,使用定量软件通过PET同时评估功能和灌注是常规做法。将射血分数储备与灌注信息相结合可能会改善对严重疾病的识别。通过对氟脱氧葡萄糖(FDG)和静息灌注成像进行定量比较,可以评估心肌存活情况。由于最新PET/CT扫描仪动态成像能力的增强,心肌血流和冠状动脉血流储备测量正逐渐常规纳入临床评估。绝对血流测量能够评估冠状动脉微血管功能障碍,并为冠心病提供额外的预后和诊断信息。已经开发出了用于从N-氨、O-水和Rb放射性示踪剂的PET动力学数据中以自动化和快速方式计算心肌血流的标准定量方法。可用于此类分析的软件方法之间的一致性非常好。基于与正常数据库比较的Rb PET心肌灌注相对定量在检测阻塞性冠状动脉疾病方面表现出高性能。新的示踪剂,如F-氟匹哒唑,可能会进一步改善疾病检测。与视觉分析相比,计算机化分析负荷和静息状态下的灌注可降低评估的变异性。通过与CT血管造影精确配准可增强PET定量。在新兴的临床应用中,已经证明通过对颈动脉、主动脉和冠状动脉中FDG和F-氟化钠示踪剂的动脉粥样硬化斑块摄取进行定量来识别易损斑块的潜力。